Looking Back at 2022: Top 5 Stories About Cancer Research and Cancer Care
My picks for five of the top cancer research stories of 2022.
5 Cancer Research Stories Worth Following – Spring 2017
Cancer research stories worth following this spring include a study on the benefits of one type of immune system therapy for patients with metastatic triple negative breast cancer.
What is “Step Therapy” and Why Should We Care?
How is the practice of “step therapy” affecting patients?
Review of “The Gene: An Intimate History” by Siddhartha Mukherjee
In the next decade, we’re likely to know much more about our individual risks for a variety of diseases and conditions based on the information contained in our genomes.
5 Cancer Research Stories Worth Following – Winter 2017
Cancer research stories worth following this winter include a possible new use for an existing drug to prevent metastasis in triple negative breast cancer.
A New Year: Where Do We Go From Here?
Let’s keep moving forward in 2017 and address health care access issues, including out-of-pocket costs, that are priorities for most Americans.
10 Things We Learned About Progress Against Cancer in 2016
Prominent issues in cancer research this year included finding ways to make immune system therapies safer and effective for more patients, and the need to make new cancer medicines more affordable.
Cancer and Health Policy: Some Things I’m Watching
Possible health policy changes in the coming months could be critical for anyone affected by or potentially affected by cancer.
5 Cancer Research Stories Worth Following – Fall 2016
Cancer research stories worth following this fall include new developments in targeted treatment for ovarian cancer and for metastatic breast cancer.
Charity Review: Dr. Susan Love Research Foundation
The Dr. Susan Love Research Foundation is known for involving the public in research on breast cancer causes and prevention.
Three Year Anniversary for After Twenty Years Cancer Research Blog
A look back on three years of blogging about cancer research from the patient perspective, and a few thoughts looking ahead.
After 20 Years 